Inflammatory and multiple hepatocellular adenoma are associated with a higher BMI.
作者： Mirelle E.E. Bröker , Marcia P. Gaspersz , Anne J. Klompenhouwer , Bettina E. Hansen , Turkan Terkivatan
DOI: 10.1097/MEG.0000000000000930
关键词:
摘要: __Aim__ To identify patient and lesion characteristics associated with the occurrence of single or multiple hepatocellular adenoma (HCA). __Patients methods__ Using a tertiary centre database, we retrospectively collected information on characteristics, management follow-up all patients HCA included between 2001 2016. Patients were classified into three groups; HCA, 2-9 at least 10 HCA. __Results__ A total 458 diagnosed including 121 (26.4%) 235 (51.3%) 102 (22.3%) Significant differences in mean BMI found, highest more than (P<0.05). The was significantly higher inflammatory compared steatotic (31 vs. 26, respectively, P<0.05). Steatotic often lesions (22/55, 40%), whereas (122/166, 73%). __Conclusion__ Our series show frequency
sci-hub.se 参考文章(40)
Henri Bismuth, Claude Degott, Jean-Pierre Benhamou, Francois Potet, Jean-Francois Flejou, Yves Menu, Janine Barge, Liver adenomatosis. An entity distinct from liver adenoma Gastroenterology. ,vol. 89, pp. 1132- 1138 ,(1985) , 10.5555/URI:PII:0016508585902203
Reeta Veteläinen, Deha Erdogan, Wilmar De Graaf, Fiebo Ten Kate, Peter L. M. Jansen, Dirk J. Gouma, Thomas M. Van Gulik, Liver adenomatosis: re‐evaluation of aetiology and management Liver International. ,vol. 28, pp. 499- 508 ,(2008) , 10.1111/J.1478-3231.2008.01669.X
C. Bunchorntavakul, R. Bahirwani, D. Drazek, M. C. Soulen, E. S. Siegelman, E. E. Furth, K. Olthoff, A. Shaked, K. R. Reddy, Clinical features and natural history of hepatocellular adenomas: the impact of obesity Alimentary Pharmacology & Therapeutics. ,vol. 34, pp. 664- 674 ,(2011) , 10.1111/J.1365-2036.2011.04772.X
Edward D. Nissen, Deryck R. Kent, Steven E. Nissen, Etiologic factors in the pathogenesis of liver tumors associated with oral contraceptives American Journal of Obstetrics and Gynecology. ,vol. 127, pp. 61- 66 ,(1977) , 10.1016/0002-9378(77)90315-5
M. Bieze, S. S. K. S. Phoa, J. Verheij, K. P. van Lienden, T. M. van Gulik, Risk factors for bleeding in hepatocellular adenoma British Journal of Surgery. ,vol. 101, pp. 847- 855 ,(2014) , 10.1002/BJS.9493
Safi Dokmak, Jacques Belghiti, Will weight loss become a future treatment of hepatocellular adenoma in obese patients Liver International. ,vol. 35, pp. 2228- 2232 ,(2015) , 10.1111/LIV.12925
Safi Dokmak, Valérie Paradis, Valérie Vilgrain, Alain Sauvanet, Olivier Farges, Dominique Valla, Pierre Bedossa, Jacques Belghiti, A Single-Center Surgical Experience of 122 Patients With Single and Multiple Hepatocellular Adenomas Gastroenterology. ,vol. 137, pp. 1698- 1705 ,(2009) , 10.1053/J.GASTRO.2009.07.061
Paulette Bioulac-Sage, Hervé Laumonier, Gabrielle Couchy, Brigitte Le Bail, Antonio Sa Cunha, Anne Rullier, Christophe Laurent, Jean-Frédéric Blanc, Gaelle Cubel, Hervé Trillaud, Jessica Zucman-Rossi, Charles Balabaud, Jean Saric, Hepatocellular adenoma management and phenotypic classification: The Bordeaux experience Hepatology. ,vol. 50, pp. 481- 489 ,(2009) , 10.1002/HEP.22995
Paulette Bioulac-Sage, Said Taouji, Laurent Possenti, Charles Balabaud, Hepatocellular adenoma subtypes: the impact of overweight and obesity Liver International. ,vol. 32, pp. 1217- 1221 ,(2012) , 10.1111/J.1478-3231.2012.02786.X
Matthias Barton, Position paper: The membrane estrogen receptor GPER--Clues and questions. Steroids. ,vol. 77, pp. 935- 942 ,(2012) , 10.1016/J.STEROIDS.2012.04.001